Outlook Therapeutics, Inc. (OTLK) Shareholders’ equity 2015–2025
Outlook Therapeutics, Inc. (OTLK) shareholders’ equity at each fiscal year-end, per SEC filings.
-$32.2MFY2025 · since FY2015: -$54.2M → -$32.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.2M | — |
| FY2019 | -$16.1M | +36.9% |
| FY2018 | -$25.5M | +24.1% |
| FY2017 | -$33.7M | -550.5% |
| FY2016 | -$5.2M | +90.5% |
| FY2015 | -$54.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice